¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

¿µ³²´ëÇб³º´¿ø Á¦6ȸ ¿µ³²±Û·Î¹ú ºñ´¢ÀÇÇÐ ½ÉÆ÷Áö¾ö : 2021-10-02

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
¿µ³²´ëÇб³º´¿ø Á¦6ȸ ¿µ³²±Û·Î¹ú ºñ´¢ÀÇÇÐ ½ÉÆ÷Áö¾ö : 2021-10-02
±³À°ÀÏÀÚ : 2021-10-02
±³À°Àå¼Ò : ¿µ³²´ëÇб³º´¿ø È£Èí±â¼¾ÅÍ ´ë°­´ç  
±³À°ÁÖÁ¦ : Á¦6ȸ ¿µ³²±Û·Î¹ú ºñ´¢ÀÇÇÐ ½ÉÆ÷Áö¾ö
ÁÖÃÖ±â°ü : ¿µ³²´ëÇб³º´¿ø
½ÃÇà±â°ü(ÁöºÎ/°ú) : ºñ´¢ÀÇÇаú  
´ã´çÀÚ : ¼ÛÇÊÇö
¿¬¶ôó : 053-620-3693  
À̸ÞÀÏ : sph04@hanmail.net      
±³À°Á¾·ù : ºñ´¢ÀÇÇаú      
Âü¼®¿¹»óÀοø : 50¸í
Èñ¸ÁÆòÁ¡ : 5Á¡  
Áö¿ª : ´ë±¸±¤¿ª½Ã
±³À°½Ã°£ : 5 ½Ã°£ 30ºÐ  
¼¼ºÎ¼ö°­·á : 0¿ø      
ºñ°í       

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 10-02 È£Èí±â¼¾ÅÍ ´ë°­´ç 10:00~10:25 I. Oncology session – What are your top concerns in urological operations? 1. Kidney Cancer  È«¼ºÈÄ(Ä«Å縯ÀÇ´ë) 
±³À°½Ã°£ 10-02 È£Èí±â¼¾ÅÍ ´ë°­´ç 10:25~10:50 I. Oncology session – What are your top concerns in urological operations? 2. Bladder Cancer  ³²Á¾±æ(ºÎ»êÀÇ´ë) 
±³À°½Ã°£ 10-02 È£Èí±â¼¾ÅÍ ´ë°­´ç 10:50~11:10 I. Oncology session – What are your top concerns in urological operations? 3. Prostate Cancer  Á¤½ÂÀÏ(Àü³²ÀÇ´ë) 
Åä·Ð 10-02 È£Èí±â¼¾ÅÍ ´ë°­´ç 11:10~11:15 panel discussion  ±èÅÂȯ(°æºÏÀÇ´ë) 
±³À°½Ã°£ 10-02 È£Èí±â¼¾ÅÍ ´ë°­´ç 11:15~11:40 II. Endourology session - Urolithiasis & ureteral stricture 1. Optimal treatment in staghorn stone  ±è¹ü¼ö(°æºÏÀÇ´ë) 
±³À°½Ã°£ 10-02 È£Èí±â¼¾ÅÍ ´ë°­´ç 11:40~12:05 II. Endourology session - Urolithiasis & ureteral stricture 2. Optimal treatment for UPJO  À±¿µÀº(ÇѾçÀÇ´ë) 
±³À°½Ã°£ 10-02 È£Èí±â¼¾ÅÍ ´ë°­´ç 12:05~12:25 II. Endourology session - Urolithiasis & ureteral stricture 3. Updates in pediatric urolithiasis  ÀÌ»óÇù(°æÈñÀÇ´ë) 
Åä·Ð 10-02 È£Èí±â¼¾ÅÍ ´ë°­´ç 12:25~12:30 panel discussion  ¿À°æÁø(Àü³²ÀÇ´ë) 
½Ä»ç 10-02  12:30~13:30 ½Ä»ç  () 
±³À°½Ã°£ 10-02 È£Èí±â¼¾ÅÍ ´ë°­´ç 13:30~13:55 III. Voiding dysfunction session – All about interstitial cystitis/bladder pain syndrome: A to Z 1. Mechanism and diagnosis of IC/BPS  ±ÇÁعü(´ë±¸ÆÄƼ¸¶º´¿ø) 
±³À°½Ã°£ 10-02 È£Èí±â¼¾ÅÍ ´ë°­´ç 13:55~14:25 III. Voiding dysfunction session – All about interstitial cystitis/bladder pain syndrome: A to Z2. Recent update on IC/BPS therapies  ±è¿µ¿í(¿µ³²ÀÇ´ë) 
Åä·Ð 10-02 È£Èí±â¼¾ÅÍ ´ë°­´ç 14:25~14:30 panel discussion  ±è°Ç³²(±¸¹ÌÂ÷ÀÇ´ë) 
±³À°½Ã°£ 10-02 È£Èí±â¼¾ÅÍ ´ë°­´ç 14:30~15:00 IV. Special session – COVID-19 vaccination & urology 1. Current status of COVID-19 vaccination in Korea  ±èÇöÁ¦(±¸¹ÌÂ÷º´¿ø) 
±³À°½Ã°£ 10-02 È£Èí±â¼¾ÅÍ ´ë°­´ç 15:00~15:25 IV. Special session – COVID-19 vaccination & urology2. The management of urologic patients related to COVID-19 vaccination  ÇÏÀ±¼®(°æºÏÀÇ´ë) 
Åä·Ð 10-02 È£Èí±â¼¾ÅÍ ´ë°­´ç 15:25~15:30 panel discussion  ±Ç»óÅÃ(¸ÇÆÄ¿öºñ´¢ÀÇÇаú) 
È޽Ġ10-02 È£Èí±â¼¾ÅÍ ´ë°­´ç 15:30~16:00 Coffee break  () 
±³À°½Ã°£ 10-02 È£Èí±â¼¾ÅÍ ´ë°­´ç 16:00~16:30 IV. Andrology session – Current status on use of testosterone in outpatient office1. Recent update on testosterone use  ½ÅÈ«¼®(´ë±¸°¡Å縯´ë) 
±³À°½Ã°£ 10-02 È£Èí±â¼¾ÅÍ ´ë°­´ç 16:30~16:55 IV. Andrology session – Current status on use of testosterone in outpatient office2. My real practice of testosterone use in outpatient office  ¿ÁºÀ±â(½Å¾Ø¼Õºñ´¢ÀÇÇаú) 
Åä·Ð 10-02 È£Èí±â¼¾ÅÍ ´ë°­´ç 16:55~17:00 panel discussion  ±èÁ¤Çö(°­³²ºñ´¢ÀÇÇаú) 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ¿µ³²´ëÇб³º´¿ø Á¦6ȸ ¿µ³²±Û·Î¹ú ºñ´¢ÀÇÇÐ ½ÉÆ÷Áö¾ö : 2021-10-02""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û (¿Â¶óÀÎ) Á¦2Â÷ ¿À»ê½ÃÀÇ»çȸ ¿Â¶óÀÎ Çмú´ëȸ : 2021-10-02
´ÙÀ½±Û (¿Â¶óÀÎ) ´ëÇѽÅÀåÇÐȸ ´ë±¸°æºÏÁöȸ ½ÉÆ÷Áö¾ö : 2021-10-02
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20694 ´ëÀü Á¦8ȸ ³»ºÐºñ ÃÊÀ½ÆÄ ¹× ±â´É°Ë»ç ¿¬¼ö°­Á : 2024-06-29 0 45 2024-05-11
20693 ¼­¿ï (¿Â¶óÀÎ) ´ëÇѼ¼Æ÷º´¸®ÇÐȸ Á¦32Â÷ º´¸®Àǻ縦 À§ÇÑ ¼¼Æ÷º´¸®±³À° 4Â÷ : 2024-06-29 0 35 2024-05-11
20692 ¼­¿ï Á¦24ȸ ´ëÇÑÀ¯Àü¼º´ë»çÁúȯÇÐȸ Á¤±âÇмú´ëȸ : 2024-06-28 0 36 2024-05-11
20691 °æ±â Á¤½Å°Ç°­ÀÇÇаú ÀÓ»ó¿¡¼­ À¯¿ëÇÑ Ä¡·á¹ý : 2024-06-26 0 44 2024-05-11
20690 ¼­¿ï (¿Â¶óÀÎ)2024 ÇѾç´ëÇб³º´¿ø È£Èí±â¾Ë·¹¸£±â ¿¬¼ö°­Á : 2024-06-22 0 38 2024-05-11
20689 ºÎ»ê °í½Å´ëÇб³º¹À½º´¿ø Á¦20ȸ °©»ó¼±¿¬¼öȸ : 2024-06-22 0 28 2024-05-11
20688 ¼­¿ï (¿Â¶óÀÎ) ´ëÇѼ¼Æ÷º´¸®ÇÐȸ Á¦32Â÷ º´¸®Àǻ縦 À§ÇÑ ¼¼Æ÷º´¸®±³À° 3Â÷ : 2024-06-22 0 9 2024-05-11
20687 ¼­¿ï ´ëÇѺÎÁ¤¸ÆÇÐȸ KHRS Annual Scientific Session 2024 (2ÀÏÂ÷) : 2024-06-22 0 12 2024-05-11
20686 ¼­¿ï Á¦50Â÷ ´ëÇѾÏÇÐȸ Çмú´ëȸ 2 : 2024-06-21 0 26 2024-05-11
20685 ¼­¿ï ´ëÇѺÎÁ¤¸ÆÇÐȸ KHRS Annual Scientific Session 2024 (1ÀÏÂ÷) : 2024-06-21 0 13 2024-05-11
20684 ¼­¿ï Á¦50Â÷ ´ëÇѾÏÇÐȸ Çмú´ëȸ 1 : 2024-06-20 0 12 2024-05-11
20683 ¼­¿ï ´ëÇѸ¶ÃëÅëÁõÀÇÇÐȸ (¿Â¶óÀÎ) ¼­¿ï°æÀÎÁöȸ 277Â÷ ¿ù·ÊÁý´ãȸ : 2024-06-18 0 31 2024-05-11
20682 ¼­¿ï 2024 °­µ¿±¸ÀÇ»çȸ Á¦3Â÷ ¿¬¼ö±³À°(¿°Áõ¼º ÀåÁúȯ,ºñ¸¸ ¾à¹° Ä¡·á ) : 2024-06-17 0 20 2024-05-11
20681 ¼­¿ï ´ëÇÑ´ç´¢º´ÇÐȸ Á¦29Â÷ ´ç´¢º´ ¿¬¼ö°­Á : 2024-06-16 0 25 2024-05-11
20680 ¼­¿ï (¿Â¶óÀÎ) ´ëÇѼ¼Æ÷º´¸®ÇÐȸ Á¦32Â÷ º´¸®Àǻ縦 À§ÇÑ ¼¼Æ÷º´¸®±³À° 2Â÷ : 2024-06-15 0 22 2024-05-11
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷